DJ Stent for Bacterial C/S (Aerobic) with Gram Stain at Chughtai Lab

DJ Stent for Bacterial C/S (Aerobic) with Gram Stain at Chughtai Lab

A Double-J (DJ) stent is a specialized, flexible urological catheter designed with curved, J-shaped ends that anchor it securely within the renal pelvis and the urinary bladder. While these stents are invaluable for maintaining ureteral patency, preventing obstruction, and facilitating urine flow after procedures like lithotripsy or ureteroplasty, they present a significant clinical challenge: biomaterial-associated infection. Over time, the synthetic surfaces of the stent become coated with host conditioning films consisting of proteins and glycoproteins. This conditioning film serves as an ideal substrate for bacterial adhesion. Bacteria utilize specialized surface structures, such as fimbriae and pili, to attach to the stent. Once attached, they replicate and secrete a protective extracellular polymeric substance (EPS) matrix, forming a highly organized bacterial biofilm. Within this biofilm, bacteria are protected from host immune defenses and are up to 1,000 times more resistant to systemic antibiotic therapy compared to their planktonic counterparts.

The DJ Stent for Bacterial C/S (Aerobic) with Gram Stain is a critical diagnostic laboratory investigation performed on a removed ureteral stent to identify colonizing or infecting aerobic bacterial pathogens and determine their antimicrobial susceptibility profiles. This test is performed at Chughtai Lab, a premier diagnostic network in Pakistan, utilizing state-of-the-art microbiological techniques. The investigation consists of two primary phases: the Gram stain and the aerobic culture and sensitivity (C/S). The Gram stain provides an immediate, preliminary microscopic visualization of the bacterial morphology (such as Gram-positive cocci or Gram-negative bacilli) and evaluates the presence of polymorphonuclear leukocytes (neutrophils), which indicates an active inflammatory response. The aerobic culture involves isolating the bacteria on selective and differential agar media, incubating them under controlled aerobic conditions, and performing standardized antibiotic susceptibility testing (AST). This comprehensive diagnostic approach is essential for differentiating simple colonization from active tissue infection, preventing life-threatening urosepsis, and guiding targeted, narrow-spectrum antimicrobial therapy.

Clinical Procedure: What to Expect

Patient Preparation

Patient preparation for the DJ Stent for Bacterial C/S (Aerobic) with Gram Stain at Chughtai Lab primarily revolves around the clinical coordination between the patient, the treating urologist, and the laboratory. Because the stent must be retrieved surgically via cystoscopy, preparation instructions are highly specific:

• Antibiotic Disclosure: Patients must provide a complete list of all antibiotics taken within the last 14 days. Current antibiotic therapy can suppress bacterial growth in vitro, leading to false-negative culture results. If clinically feasible, the urologist may recommend a brief antibiotic-free window prior to stent removal.
• Pre-Procedural Hydration: Adequate oral hydration is generally encouraged prior to the cystoscopy procedure to facilitate urine flow and help flush out loose debris, unless contraindicated by a physician due to renal insufficiency or severe obstruction.
• Surgical Preparation: Since the stent is retrieved via a cystoscopic procedure, patients must follow the specific fasting and preparation guidelines provided by their urologist, especially if the procedure is to be performed under regional or general anesthesia rather than local anesthesia.
• Hygiene Protocols: Thorough perineal hygiene with soap and water is recommended on the morning of the procedure to minimize the risk of introducing external skin flora into the sterile field during cystoscopy.
• Co-requisite Testing: A routine urinalysis and voided urine culture are often ordered concurrently to compare the bacterial profile of the urine with that of the stent biofilm.

During the Procedure

The collection of the DJ stent specimen is a sterile surgical procedure performed by a qualified urologist in a clinical or operating room setting. The patient is positioned comfortably on a cystoscopy table, typically in the lithotomy position. After administering appropriate anesthesia (local anesthetic gel, regional block, or general anesthesia) and preparing the urethral meatus with an antiseptic solution, the urologist inserts a cystoscope through the urethra into the urinary bladder. Under direct visualization, the urologist locates the distal loop of the DJ stent in the bladder, grasps it using sterile endoscopic forceps, and gently withdraws the stent from the ureter.

Once the stent is removed from the patient’s body, strict aseptic technique is maintained to prevent contamination with urethral or environmental microflora. Using sterile scissors, the urologist cuts a segment of the stent—typically the proximal renal coil, the distal vesical coil, or both—and places it directly into a sterile specimen container. The container is sealed immediately, labeled with the patient’s unique identifiers, and transported rapidly to the microbiology laboratory at Chughtai Lab. In the laboratory, technicians process the stent segment using specialized methods, such as the Maki roll-plate method or sonication, to dislodge the biofilm-associated bacteria from the biomaterial surface. The dislodged sample is then used to prepare a Gram stain smear and is inoculated onto culture plates, including Blood Agar and MacConkey Agar, which are incubated at 35-37°C under aerobic conditions for up to 48 hours.

When is a DJ Stent for Bacterial C/S (Aerobic) with Gram Stain Performed?

Suspected Stent-Associated Urinary Tract Infection (SUTI)

Physicians request this test when a patient with an indwelling ureteral stent exhibits clinical symptoms of a urinary tract infection. These symptoms include persistent dysuria, increased urinary frequency, urgency, suprapubic pain, or flank pain. Because the symptoms of stent irritation can overlap significantly with those of an infection, the DJ Stent for Bacterial C/S (Aerobic) with Gram Stain is crucial for confirming the presence of an active bacterial pathogen and distinguishing it from simple mechanical irritation caused by the stent.

Unexplained Post-Procedural Fever and Systemic Symptoms

If a patient develops an unexplained fever, chills, rigors, tachycardia, or hypotension following the removal or manipulation of a ureteral stent, urosepsis must be suspected. During stent removal, the mechanical disruption of the biofilm can release bacteria and endotoxins directly into the bloodstream. Culturing the removed stent allows clinicians to rapidly identify the specific organism responsible for the systemic inflammatory response and tailor intravenous antibiotic therapy accordingly.

Persistent Pyuria or Bacteriuria Despite Empiric Therapy

When a patient continues to show high levels of white blood cells (pyuria) or bacteria (bacteriuria) in their routine urinalysis despite receiving standard empiric antibiotic treatment, a resistant biofilm infection is highly likely. The DJ Stent for Bacterial C/S (Aerobic) with Gram Stain is performed to identify multi-drug resistant (MDR) organisms that are protected within the stent biofilm and to determine their specific antibiotic susceptibility patterns, allowing for targeted therapeutic adjustments.

Routine Surveillance Following Long-Term Indwelling Stents

Ureteral stents left in place for extended periods (typically exceeding 6 to 12 weeks) have an extremely high rate of bacterial colonization and encrustation. Even in asymptomatic patients, urologists frequently request a culture of the stent upon its removal. This proactive approach helps detect highly resistant subclinical pathogens that could cause severe delayed infections or complicate subsequent urological interventions, such as secondary stone surgeries.

Pre-operative Risk Mitigation in High-Risk Patients

In patients with significant comorbidities—such as diabetes mellitus, chronic kidney disease, advanced age, or immunosuppression—uncontrolled urinary tract infections can rapidly escalate into life-threatening complications. When these patients undergo stent removal or exchange, culturing the stent is vital to ensure that any colonizing pathogen is identified and treated before it can cause pyelonephritis, renal abscess, or systemic bacteremia.

What Does a DJ Stent for Bacterial C/S (Aerobic) with Gram Stain Detect?

The DJ Stent for Bacterial C/S (Aerobic) with Gram Stain is designed to detect a wide array of microbiological and clinical parameters, including:

• Gram-Negative Bacilli: Microscopic identification of rod-shaped bacteria, which are the most common causative agents of urinary tract infections.
• Gram-Positive Cocci: Microscopic identification of spherical bacteria arranged in chains, pairs, or clusters, indicating potential streptococcal, enterococcal, or staphylococcal colonization.
• Polymorphonuclear Leukocytes (Neutrophils): The presence of white blood cells on the Gram stain smear, confirming an active host inflammatory response rather than simple environmental contamination.
• Escherichia coli: The most prevalent uropathogen isolated from ureteral stents, known for its rapid colonization and biofilm formation capabilities.
• Klebsiella pneumoniae: A common Gram-negative pathogen associated with severe, nosocomial urinary infections and high rates of antibiotic resistance.
• Proteus mirabilis: A urease-producing bacterium that splits urea into ammonia, raising urinary pH and promoting the precipitation of struvite crystals, leading to severe stent encrustation.
• Pseudomonas aeruginosa: An opportunistic, highly resilient Gram-negative rod that forms robust biofilms and is notoriously resistant to multiple classes of antibiotics.
• Enterococcus faecalis: A Gram-positive coccus commonly found in the gastrointestinal tract that can colonize urological biomaterials and cause persistent infections.
• Enterococcus faecium: A highly resistant enterococcal species often associated with healthcare-acquired infections and resistance to vancomycin.
• Staphylococcus epidermidis: A coagulase-negative staphylococcus that readily adheres to synthetic biomaterials and forms dense biofilms on ureteral stents.
• Staphylococcus aureus: A virulent Gram-positive pathogen that can cause severe localized and systemic infections if introduced into the urinary tract.
• Enterobacter cloacae: An opportunistic pathogen capable of causing complicated urinary tract infections, particularly in hospitalized patients.
• Serratia marcescens: A Gram-negative bacterium known for its ability to colonize indwelling medical devices and resist various disinfectants and antibiotics.
• Acinetobacter baumannii: A multi-drug resistant Gram-negative pathogen occasionally isolated from long-term indwelling stents in intensive care settings.
• Polymicrobial Colonization: The presence of multiple distinct bacterial species within the same stent biofilm, which is common in long-term stenting.
• Extended-Spectrum Beta-Lactamase (ESBL) Production: Detection of enzymes produced by Gram-negative bacteria that confer resistance to penicillins, cephalosporins, and monobactams.
• Carbapenem-Resistant Enterobacteriaceae (CRE): Identification of highly resistant bacterial strains that limit treatment options to last-resort antibiotics.
• Methicillin-Resistant Staphylococcus aureus (MRSA): Detection of staphylococcal strains resistant to beta-lactam antibiotics, requiring specialized therapeutic agents.
• Vancomycin-Resistant Enterococci (VRE): Identification of enterococcal strains resistant to glycopeptides, indicating a highly resistant clinical scenario.
• Minimum Inhibitory Concentration (MIC): Quantitative determination of the lowest concentration of an antibiotic that prevents visible bacterial growth, guiding precise dosing.
• Susceptibility to Fluoroquinolones: Evaluation of bacterial sensitivity to commonly prescribed oral urological antibiotics like Ciprofloxacin and Levofloxacin.
• Susceptibility to Aminoglycosides: Assessment of sensitivity to potent intravenous agents such as Amikacin and Gentamicin.
• Susceptibility to Carbapenems: Determination of bacterial vulnerability to broad-spectrum agents like Meropenem and Imipenem.
• Susceptibility to Cephalosporins: Evaluation of sensitivity to third- and fourth-generation cephalosporins (e.g., Ceftriaxone, Cefepime).
• Absence of Aerobic Growth: A negative culture result indicating that no viable aerobic bacteria were isolated from the stent segment after adequate incubation.

Turnaround Time and Report Access at Chughtai Lab

At Chughtai Lab, the reporting process for the DJ Stent for Bacterial C/S (Aerobic) with Gram Stain is structured to provide both rapid preliminary information and highly accurate definitive results. The Gram stain report, which provides immediate microscopic findings regarding bacterial morphology and inflammatory cells, is typically completed within a few hours of specimen receipt. This rapid turnaround allows clinicians to make immediate, informed decisions regarding empiric antibiotic therapy while the culture is ongoing.

The aerobic culture and sensitivity phase requires a longer processing time. Initial culture plates are evaluated after 24 hours of incubation. If bacterial growth is detected, subsequent identification and automated antibiotic susceptibility testing (AST) are performed, which require an additional 18 to 24 hours. Therefore, a final, comprehensive report detailing the exact bacterial species and its complete antibiotic susceptibility profile is generally available within 48 to 72 hours. Chughtai Lab offers seamless digital access to reports. Patients and physicians receive an automated SMS notification once the results are finalized. Reports can be viewed, downloaded, and printed online via the official Chughtai Lab website or through the Chughtai Healthcare Mobile App, ensuring prompt clinical intervention.

DJ Stent for Bacterial C/S (Aerobic) with Gram Stain Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Gram Stain Microscopic Smear	No bacteria seen; No or occasional polymorphonuclear leukocytes (PMNs)	Gram-negative bacilli or Gram-positive cocci detected; Moderate to abundant PMNs (indicating active inflammation)
Aerobic Culture (Agar Plates)	No growth of aerobic bacteria after 48 hours of incubation	Significant growth of uropathogens (e.g., E. coli, Pseudomonas, Klebsiella, or Enterococcus species)
Bacterial Biofilm Load	No colonization detected on the stent surface	High colony counts of biofilm-associated bacteria (e.g., >1,000 colony-forming units per segment)
Antibiotic Susceptibility Profile	Not applicable (no bacterial growth)	Identification of specific resistance patterns (e.g., ESBL, CRE, MRSA, or VRE phenotypes)
Urease Activity of Isolates	Negative (no urease-producing bacteria)	Positive urease activity (e.g., Proteus mirabilis), indicating a high risk of stent encrustation and stone formation
Inflammatory Cell Count	0 – 5 white blood cells per high-power field (HPF)	>10 white blood cells per HPF, confirming localized tissue response to infection
Fungal Co-infection (if noted)	No yeast or fungal elements observed	Presence of Candida species or other fungal elements, suggesting opportunistic fungal colonization

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for DJ Stent for Bacterial C/S (Aerobic) with Gram Stain?

• CAP Accreditation: Chughtai Lab operates under the stringent quality standards of the College of American Pathologists (CAP), ensuring international-grade accuracy and reliability in microbiology reporting.
• Expert Microbiologists: All laboratory investigations are supervised and interpreted by highly qualified Consultant Pathologists and Microbiologists with extensive clinical experience.
• Advanced Automation: The laboratory utilizes cutting-edge, automated identification and susceptibility testing systems (such as VITEK® 2) to deliver rapid and highly precise minimum inhibitory concentration (MIC) values.
• Strict Quality Control: Chughtai Lab adheres to the latest Clinical and Laboratory Standards Institute (CLSI) guidelines for antimicrobial susceptibility testing, ensuring therapeutic relevance.
• Rapid Preliminary Reporting: Direct Gram stain results are processed and reported swiftly to assist clinicians in initiating early, targeted therapy.
• Seamless Digital Integration: Patients can access their diagnostic reports instantly via the secure online portal or the Chughtai Healthcare Mobile App from anywhere in Pakistan.
• Nationwide Network: With a vast network of collection centers across major cities like Lahore, Karachi, and Islamabad, Chughtai Lab offers unparalleled accessibility and convenience.
• Comprehensive Patient Care: Chughtai Lab provides a patient-centric environment with dedicated customer support, secure electronic medical record (EMR) archiving, and reliable critical value notification systems.